Terms: = Prostate cancer AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9
2344 results:
1. Incretin-based drugs decrease the incidence of prostate cancer in type 2 diabetics: A pooling-up analysis.
Lin Y; Xu G; Li L; Xiang J; Zhai L
Medicine (Baltimore); 2024 May; 103(20):e38018. PubMed ID: 38758855
[TBL] [Abstract] [Full Text] [Related]
2. The impact of prostate volume estimation on the risk-adapted biopsy decision based on prostate-specific antigen density and magnetic resonance imaging score.
Baudewyns A; Guenzel K; Halinski A; Dariane C; Delavar G; Anract J; Barry Delongchamps N; Jabbour T; Bourgeno HA; Lefebvre Y; Ferriero M; Simone G; Fourcade A; Fournier G; Oderda M; Gontero P; Bernal-Gomez A; Mastrorosa A; Roche JB; Zahr RA; Ploussard G; Fiard G; Rysankova K; Bui AP; Taha F; Windisch O; Benamran D; Vlahopoulos L; Assenmacher G; Roumeguère T; Peltier A; Diamand R
World J Urol; 2024 May; 42(1):322. PubMed ID: 38747982
[TBL] [Abstract] [Full Text] [Related]
3. PAX6 promotes neuroendocrine phenotypes of prostate cancer via enhancing met/STAT5A-mediated chromatin accessibility.
Jing N; Du X; Liang Y; Tao Z; Bao S; Xiao H; Dong B; Gao WQ; Fang YX
J Exp Clin Cancer Res; 2024 May; 43(1):144. PubMed ID: 38745318
[TBL] [Abstract] [Full Text] [Related]
4. Treatment Patterns and Attrition With Lines of Therapy for Advanced Urothelial Carcinoma in the US.
Mathew Thomas V; Jo Y; Tripathi N; Roy S; Chigarira B; Narang A; Gebrael G; Hage Chehade C; Sayegh N; Galarza Fortuna G; Ji R; Campbell P; Li H; Agarwal N; Gupta S; Swami U
JAMA Netw Open; 2024 May; 7(5):e249417. PubMed ID: 38696168
[TBL] [Abstract] [Full Text] [Related]
5. Role of antihypertensive medicines in prostate cancer: a systematic review.
Iheanacho CO; Enechukwu OH
BMC Cancer; 2024 Apr; 24(1):542. PubMed ID: 38684963
[TBL] [Abstract] [Full Text] [Related]
6. Optimizing outcomes in men with prostate cancer: the cardiovascular event lowering (CaELo) pathways.
Crawford DE; Albala D; Garnick MB; Hahn AW; Maroni P; McKay RR; Miner M; Orio Ⅲ P; Pandit K; Sellinger S; Yu EY; Eckel RH
Can J Urol; 2024 Apr; 31(2):11820-11825. PubMed ID: 38642459
[TBL] [Abstract] [Full Text] [Related]
7. A systematic review of combined surgery and brachytherapy approaches for children and young people with relapsed and refractory rhabdomyosarcoma (Local-REFoRMS).
Ballantyne E; Evans C; Shepherd L; Fulbright H; Wakeling S; Phillips B; Morgan JE
Pediatr Blood Cancer; 2024 Jun; 71(6):e30952. PubMed ID: 38566349
[TBL] [Abstract] [Full Text] [Related]
8. MRI-based radiomics for prediction of extraprostatic extension of prostate cancer: a systematic review and meta-analysis.
Wen J; Liu W; Zhang Y; Shen X
Radiol Med; 2024 May; 129(5):702-711. PubMed ID: 38520649
[TBL] [Abstract] [Full Text] [Related]
9. Compliance With NCCN Guidelines for Evaluation and Treatment of Anemia Among Patients With Solid Tumors.
Hufnagel DH; Bos LM; Brown AJ; Prescott LS
J Natl Compr Canc Netw; 2024 Mar; 22(3):. PubMed ID: 38489926
[TBL] [Abstract] [Full Text] [Related]
10. Evaluation of Cutoff Point prostate Specific Antigen (PSA) and prostate Specific Antigen Density (PSAD) in Patients with Suspected prostate cancer.
Daryanto B; Trianto R; Seputra KP; Purnomo AF
Med Arch; 2024; 78(1):12-15. PubMed ID: 38481588
[TBL] [Abstract] [Full Text] [Related]
11. Morphologic features of prostate cancer-encased native vessels: An image analysis study.
Fernandez Gonzalez De La Vega C; Duenweg S; Jain P; Rubenstein SI; Bobholz S; Barrett MJ; LaViolette PS; Iczkowski KA
Pathol Res Pract; 2024 Apr; 256():155239. PubMed ID: 38461692
[TBL] [Abstract] [Full Text] [Related]
12. Design, synthesis, and biological evaluation of novel quinoxaline aryl ethers as anticancer agents.
Nakka S; Raza A; Chaitanya KS; Bandaru NVMR; Chandu A; Murugesan S; Devunuri N; Sharma AK; Chandrasekhar KVG
Chem Biol Drug Des; 2024 Mar; 103(3):e14502. PubMed ID: 38453260
[TBL] [Abstract] [Full Text] [Related]
13. prostate cancer in Spain: A retrospective database analysis of hospital incidence and the direct medical costs.
Darbà J; Ascanio M
PLoS One; 2024; 19(3):e0298764. PubMed ID: 38451968
[TBL] [Abstract] [Full Text] [Related]
14. Use, applicability, and dissemination of patient versions of clinical practice guidelines in oncology in Germany: a qualitative interview study with healthcare providers.
Wahlen S; Breuing J; Becker M; Bühn S; Hauprich J; Könsgen N; Meyer N; Blödt S; Carl G; Follmann M; Frenz S; Langer T; Nothacker M; Schaefer C; Pieper D
BMC Health Serv Res; 2024 Mar; 24(1):272. PubMed ID: 38439061
[TBL] [Abstract] [Full Text] [Related]
15. Demonstrating Bioequivalence for Two Dose Strengths of Niraparib and Abiraterone Acetate Dual-Action Tablets Versus Single Agents: Utility of Clinical Study Data Supplemented with Modeling and Simulation.
Yu A; Hazra A; Jiao JJ; Hellemans P; Mitselos A; Tian H; Ruixo JJP; Haddish-Berhane N; Ouellet D; Russu A
Clin Pharmacokinet; 2024 Apr; 63(4):511-527. PubMed ID: 38436924
[TBL] [Abstract] [Full Text] [Related]
16.
Duan H; Moradi F; Davidzon GA; Liang T; Song H; Loening AM; Vasanawala S; Srinivas S; Brooks JD; Hancock S; Iagaru A
Lancet Oncol; 2024 Apr; 25(4):501-508. PubMed ID: 38423030
[TBL] [Abstract] [Full Text] [Related]
17. Magnetic resonance guided adaptive post prostatectomy radiotherapy: Accumulated dose comparison of different workflows.
Hassan SP; de Leon J; Batumalai V; Moutrie Z; Hogan L; Ge Y; Stricker P; Jameson MG
J Appl Clin Med Phys; 2024 Apr; 25(4):e14253. PubMed ID: 38394627
[TBL] [Abstract] [Full Text] [Related]
18. Development of depression in patients using androgen deprivation therapy: A systemic review and meta-analysis.
Qazi SU; Altaf Z; Zafar M; Tariq MA; Khalid A; Kaleem A; Saad E; Qazi S
Prostate; 2024 May; 84(6):525-538. PubMed ID: 38372065
[TBL] [Abstract] [Full Text] [Related]
19. 1,3-Disubstituted-1,2,4-triazin-6-ones with potent activity against androgen receptor-dependent prostate cancer cells.
Zhao S; Ali AS; Liu X; Yu Z; Kong X; Zhang Y; Paul Savage G; Xu Y; Lin B; Wu D; Francis CL
Bioorg Med Chem; 2024 Mar; 101():117634. PubMed ID: 38359754
[TBL] [Abstract] [Full Text] [Related]
20. prostate cancer Screening Uptake in Transgender Women.
Kalavacherla S; Riviere P; Kalavacherla S; Anger JT; Murphy JD; Rose BS
JAMA Netw Open; 2024 Feb; 7(2):e2356088. PubMed ID: 38353948
[TBL] [Abstract] [Full Text] [Related]
[Next]
